The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Dominic Allocco

Showing 1-14 of 14 articles
Coronary interventions
A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis
Hamm C, Dörr O, Woehrle J, Krackhardt F, Ince H, Zeus T, Berland J, Piot C, Roubille F, Schult I, Allocco D, Nef H
July 17, 2020 | 10.4244/EIJ-D-19-00051
Interventions for valvular disease
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R, Worthley S, Whitbourn R, Montarello J, Newcomb A, Allocco D, Meredith I
December 7, 2018 | 10.4244/EIJ-D-18-00664
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study
Han Y, Liu H, Yang Y, Zhang J, Xu K, Fu G, Su X, Jiang T, Pang W, Chen J, Yuan Z, Li H, Wang H, Hong T, Liu H, Sun F, Allocco D, Zhang M, Dawkins K
November 20, 2017 | 10.4244/EIJ-D-17-00271
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)
Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco D, Dawkins K
March 20, 2015 | 10.4244/EIJY15M01_01
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I, Worthley S, Whitbourn R, Antonis P, Montarello J, Newcomb A, Lockwood S, Haratani N, Allocco D, Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Boston Scientific Lotus valve
Meredith I, Hood K, Haratani N, Allocco D, Dawkins K
September 30, 2012 | 10.4244/EIJV8SQA12
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials
Kereiakes D, Popma J, Cannon L, Kandzari D, Kimmelstiel C, Meredith I, Teirstein P, Verheye S, Allocco D, Dawkins K, Stone G
June 27, 2012 | 10.4244/EIJV8I2A32
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
Meredith I, Whitbourn R, Scott D, El-Jack S, Zambahari R, Stone G, Teirstein P, Starzyk R, Allocco D, Dawkins K
May 17, 2011 | 10.4244/EIJV7I1A15
First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent
Ormiston J, Lefèvre T, Grube E, Allocco D, Dawkins K
May 25, 2010
Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial
Hopkins L, Myla S, Grube E, Eles G, Dave R, Jaff M, Allocco D
April 12, 2010

Latest news

NEW ISSUE
State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more
October 20, 2021
STATE OF THE ART
Valve-in-valve TAVI: a practical overview
Giuseppe Tarantini et al.
October 20, 2021
AHEAD OF PRINT
TAVI in younger (<70 years old) patients: the AMTRAC registry
Guy Witberg et al.
October 22, 2021
AHEAD OF PRINT
Impact of LVOT calcification in transfemoral TAVI patients
L. Waldschmidt et al.
October 19, 2021
VIEWPOINT
My Stroke Story
Marco Noc
October 20, 2021
AHEAD OF PRINT
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial
Hironori Hara et al.
October 22, 2021
AHEAD OF PRINT
Serum caffeine causes adenosine-induced FFR overestimation
Hideaki Tanaka et al.
October 15, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke